Purdue Claims Construction Prevails In Embeda IP Suit

Law360, New York (June 24, 2010, 4:27 PM ET) -- A federal judge has largely adopted Purdue Pharma LP's proposed claims construction in a declaratory judgment suit brought by King Pharmaceuticals Inc. and Alpharma Inc. — the makers of oral opioid analgesic Embeda — over two Purdue-held patents for tamper-resistant painkiller formulations.

The order laying out the proper construction of certain claims of the patents-in-suit, which both put forth inventions engineered to combat abuse of opioid pain prescription medications, was issued Tuesday by Judge James P. Jones of the U.S. District Court for the Western District...
To view the full article, take a free trial now.
Try Law360 for free for seven days
Already a subscriber? Click here to login

Already have access?

  1. Forgot your password?
  2. Sign In

Get instant access to the one-stop news source for business lawyers